Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation
about
Immune Reconstitution after Allogeneic Hematopoietic Stem Cell TransplantationDifferential Response of Mouse Thymic Epithelial Cell Types to Ionizing Radiation-Induced DNA Damage.Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.Chimeric NKG2D T cells require both T cell- and host-derived cytokine secretion and perforin expression to increase tumor antigen presentation and systemic immunity.Long-term leukocyte reconstitution in NSG mice transplanted with human cord blood hematopoietic stem and progenitor cells.Interleukin-21 promotes thymopoiesis recovery following hematopoietic stem cell transplantation.Progress toward curing HIV infections with hematopoietic stem cell transplantation.Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cellsComment on "5-azacytidine promotes an inhibitory T-cell phenotype and impairs immune mediated antileukemic activity"Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantationProof-of-Principle for Immune Control of Global HIV-1 Reactivation In Vivo.Factors influencing lymphocyte reconstitution after allogeneic hematopoietic stem cell transplantation in children.Therapeutic cancer vaccines: current status and moving forward.Studies of lymphocyte reconstitution in a humanized mouse model reveal a requirement of T cells for human B cell maturationBone Marrow Stromal Cell Intraspinal Transplants Fail to Improve Motor Outcomes in a Severe Model of Spinal Cord Injury.Rituximab-based treatments followed by adoptive cellular immunotherapy for biopsy-proven EBV-associated post-transplant lymphoproliferative disease in recipients of allogeneic hematopoietic stem cell transplantation.Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusion.Translational Mini-Review Series on B cell subsets in disease. Reconstitution after haematopoietic stem cell transplantation - revelation of B cell developmental pathways and lineage phenotypes.Immunologic approaches for the treatment of multiple myeloma.Thymosin alpha 1 and HIV-1: recent advances and future perspectives.Peripheral blood Th9 cells reconstitution and its relationship with acute graft-versus-host disease after matched-sibling peripheral blood hematopoietic stem cell transplantation.Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantation.Lymphocyte recovery and infused CD34+ cells dose: Effect on the evolution after stem cell autotransplantation.Immune reconstitution after allogeneic hematopoietic stem cell transplantation in children: a single institution study of 59 patients.Quantification of CD8(+)CD38(+) T lymphocytes by flow cytometry does not represent a good biomarker to monitor the reactivation of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.Relationship between cytomegalovirus (CMV) reactivation, CMV-driven immunity, overall immune recovery and graft-versus-leukaemia effect in children.Changes in the number of CD8⁺ T lymphocytes in the peripheral blood of patients with various autoimmune diseases after autologous hematopoietic stem cell transplantations and their relations to the survival times.Mucosal-Associated Invariant T Cells Display a Poor Reconstitution and Altered Phenotype after Allogeneic Hematopoietic Stem Cell Transplantation.Safe and effective administration of BCG for bladder carcinoma in situ after umbilical cord blood stem cell transplantation.Prognostic impact of lymphocyte subpopulations in peripheral blood after hematopoietic stem cell transplantation for hematologic malignancies.Delay of Alternative Antiviral Therapy and Poor Outcomes of Acyclovir-Resistant Herpes Simplex Virus Infections in Recipients of Allogeneic Stem Cell Transplant.Real Time Immunophenotyping of Leukocyte Subsets Early after Double Cord Blood Transplantation Predicts Graft Function.Early lymphocyte recovery at 28 d post-transplant is predictive of reduced risk of relapse in patients with acute myeloid leukemia transplanted with peripheral blood stem cell grafts.The Transcription Factor Hif-1 Enhances the Radio-Resistance of Mouse MSCs.Restoring T Cell Homeostasis After Allogeneic Stem Cell Transplantation; Principal Limitations and Future Challenges.
P2860
Q28072627-69F3D8E3-FAF5-4396-9308-3A863F32DA16Q33559220-2C57822C-FCA5-438B-BAFF-D693F6AC784FQ33627040-6E6A9BA3-F6B9-454D-88D4-B7DDC6061733Q33671322-81F5DE62-8EE5-4826-BD26-87E3896C938EQ33742461-57314E2E-12E6-4640-BD91-512675EA9ADDQ33802076-237C2D33-7559-4B4A-A1AA-C781860C96A8Q34974480-B0DF36D5-2BC1-426C-8BA4-6049E55DD78DQ34985537-18F07131-7F79-4C97-BDEC-7437D7A12EA6Q35207569-B69F218A-D644-499A-A719-1A959B409545Q35613207-F9E6DDED-13AE-420F-9FD9-2583A2211123Q35718251-0E2138DC-D125-43F0-894E-068584A4C8B7Q35865589-C633AB80-54AA-40C0-899A-9924CEF97D51Q35894347-5213A5EB-A17C-4C5B-8F4B-2B9947E9CA5AQ36626153-3F733A86-78F4-42D7-8A01-1566364501CAQ36996232-ED0C12C5-E97C-4AF9-981A-577202E7023BQ37012569-136C6792-9920-46AB-8785-80CA05EE5C03Q37609441-13973584-AE63-48E7-9E2C-8890D03BB5AAQ37963475-23929382-D846-4BC3-AB8C-21ECE28C0FB4Q38692244-BEB751B4-B28A-4BDC-A219-41CF8E5B3CF8Q38768132-321D3781-AB59-4D6F-A9CB-371CB8D31A59Q41549282-FB5FB348-1753-4505-AA07-3AD3545A734BQ41720338-D5D46410-80C6-4763-BFF2-CC4BB9B25EDDQ41893175-3EF297DA-8E0F-4241-86C6-EAEDDF079DC0Q42083118-14E0D7DD-B897-4411-B478-40AF69FDC4C9Q42140510-04ED94D8-A028-49DE-886B-8910FBF13613Q42226854-8932DA90-4D1F-4CE0-903C-E6F6DB772C2BQ45732703-C4943515-2F55-429A-829D-5A06CBE50656Q47194084-FFE89EE7-176F-4AA0-97D6-57AE01CB74D2Q48258318-7FA5C803-2C53-4517-8FA1-E13D6884E026Q48709199-7511C39F-6267-49D8-AE18-001BCDFE8496Q49719887-07B48918-7337-43AF-B8E4-08F65D3E28B4Q50994231-BB06DB4C-EB98-4F92-B2A5-19A502E73AA1Q53058361-3119E15A-44B0-41FA-B18F-815625DEF6D6Q53683197-F8326314-3066-4026-8F04-E7BA427D8E0FQ55410263-2397E52D-D500-4144-8146-61F6FB20647F
P2860
Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Immune reconstitution and impl ...... etic stem cell transplantation
@en
type
label
Immune reconstitution and impl ...... etic stem cell transplantation
@en
prefLabel
Immune reconstitution and impl ...... etic stem cell transplantation
@en
P2860
P1476
Immune reconstitution and impl ...... etic stem cell transplantation
@en
P2093
Kirsten M Williams
Ronald E Gress
P2860
P304
P356
10.1016/J.BEHA.2008.06.003
P577
2008-09-01T00:00:00Z